Immune Reconstitution after Autologous Hematopoietic Cell Transplant (AHCT) in B-Cell Non-Hodgkin Lymphoma (B-NHL) Patients Mobilized with Granulocyte Colony Stimulating Factor (G-CSF), with or without Plerixafor Pallawi Torka, MD, Paul K. Wallace, PhD, Yali Zhang, MPH, George L. Chen, MD, Christine M. Ho, MD, Sophia R. Balderman, MD, Maureen Ross, MD, PhD, Bruno Paiva, PhD, Francisco J. Hernandez-Ilizaliturri, MD, Philip L. McCarthy, MD, Theresa E. Hahn, PhD Biology of Blood and Marrow Transplantation Volume 22, Issue 3, Pages S155-S156 (March 2016) DOI: 10.1016/j.bbmt.2015.11.508 Copyright © 2016 Terms and Conditions
Figure 1 Early ALC recovery is not associated with improved PFS or OS in B-NHL patients in CR pre-AHCT Biology of Blood and Marrow Transplantation 2016 22, S155-S156DOI: (10.1016/j.bbmt.2015.11.508) Copyright © 2016 Terms and Conditions
Figure 2 Higher proportions of CD8+ central memory (CM) T-cells are associated with worse PFS and OS in B-NHL patients in CR pre-AHCT Biology of Blood and Marrow Transplantation 2016 22, S155-S156DOI: (10.1016/j.bbmt.2015.11.508) Copyright © 2016 Terms and Conditions